Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | -3.40% | -14.67% | +26.73% |
05-15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.73% | 81.64M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Goldman Sachs Adjusts Price Target for Passage Bio to $2 From $4, Maintains Neutral Rating